Skip to content

Hippocampal Volume and Memory Functions in Aneurysmal Subarachnoid Hemorrhage

Investigation of the Relationship Between Hippocampal Volume and Memory Functions in in Patients With Aneurysmal Subarachnoid Hemorrhage (aSAH)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04449666
Enrollment
30
Registered
2020-06-29
Start date
2020-06-15
Completion date
2026-12-15
Last updated
2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurologic Disorder, Subarachnoid Hemorrhage, Aneurysmal

Keywords

Neurological rehabilitation, Hippocampal volume, Memory deficits

Brief summary

Neuropsychological and functional long-term consequences of subarachnoid hemorrhages (SAH) represent a great challenge, since sometimes considerable cognitive deficits occur without evidence of substantial brain damage. In this study, we want to examine if the frequently observed memory deficits are associated with hippocampal atrophy.

Detailed description

Long-term or even permanent neuropsychological impairments are frequently observed after aneurysmal subarachnoid hemorrhages (aSAH). Among the most common impairments after aSAH are memory deficits. Volumetric MRI studies suggest an association of memory dysfunctions with temporal atrophy, especially of the hippocampus. In a previous study, 77 patients with good or moderate clinical outcome after aSAH were examined one year after discharge (Bendel et al., 2006). Temporomesial atrophy was detected without direct brain damage, e.g. by secondary ischemia. Due to the effects of complex cognitive impairments on the quality of life and participation in social and professional life, this relationship will be examined in more detail in the planned study. Specifically, we will investigate to what extent the frequently observed discrepancy between severe memory impairment and normal structural imaging results (no focal lesions in temporomesial areas) is due to hippocampal atrophy. In contrast to Bender and colleagues, this question will be investigated in the acute phase of the disease, immediately after admission to inpatient neurological rehabilitation. Over a period of 24 months, 29 neurological rehabilitation patients with aSAH (Hunt & Hess grade I and II) are going to be included. Within the first week (day 1 to 7) after study enrollment, a native MRI examination (without contrast agent) is performed, in which a high-resolution 3D-MPRAGE sequence (T1 weighting) is measured in the sagittal plane. After checking the data quality of the 3D-MPRAGE sequence, especially with regard to its suitability for hippocampal volume determination, a comprehensive neuropsychological examination is performed, in which specific memory and attentional functions are tested.

Interventions

DIAGNOSTIC_TESTNeuropsychological assessment and structural MRI

Complex neuropsychological assessment testing attentional and memory functions. Additionally, a structural MRI is measured.

Sponsors

BDH-Klinik Hessisch Oldendorf
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years

Inclusion criteria

* neurological rehabilitation patients in phase B - D * at minimum eight weeks after disease onset * aneurysmal subarachnoid hemorrhage (Hunt & Hess grade I or II) * written consent from the patient's legal representative * exclusion of pregnancy

Exclusion criteria

* insufficient cardiorespiratory stability * previous brain damage * mental disorders (dementia, depression) * colonization with multi-resistant pathogens * MRI contraindications * claustrophobia * weight \> 120 kg

Design outcomes

Primary

MeasureTime frameDescription
Changed hippocampal volume in aSAB2 weeksHypothesis: patients have smaller hippocampal volume than healthy control subjects. For the hippocampal volume a structural MRI scan (3D-MPRAGE) is obtained

Secondary

MeasureTime frameDescription
Changed memory function in aSAB2 weeksHypothesis: patients have lower scores in the Visual and Verbal memory test (VVM) than healthy control subjects.
Influence of the type of therapy on the hippocampal volume2 weeksHypothesis: hippocampal volumes differ between aSAH patients with surgical or endovascular treatment.
Influence of the lesion site on the hippocampal volume2 weeksHypothesis: there are no differences between ispi- and contralateral hippocampal volumes
Interrater reliability2 weeksHypothesis: It is expected that there will be no difference in the ratings of hippocampal volume between two independent raters.
Changed intracranial volume in aSAB2 weeksHypothesis: patients have smaller intracranial volume than healthy control subjects.

Countries

Germany

Contacts

Primary ContactMelanie Boltzmann, PhD
m.boltzmann@bdh-klinik-hessisch.oldendorf0049 5152 781 256
Backup ContactSimone B Schmidt, PhD
si.schmidt@bdh-klinik-hessisch.oldendorf0049 5152 781 215

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026